5 completed, 1 unknown, 1 withdrawn. 4 Phase 2, 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Unknown 1, Withdrawn 1 |
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Completed 1 |
Follow Valchlor: new trials by email Literature Review of Valchlor trials Research Report on Valchlor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL Hypericin, Mechlorethamine Topical Gel - Cutaneous T-Cell Lymphoma/Mycosis Fungoides | Phase 2 | Completed | Soligenix | 10 | 2023-12-05 | 2025-08-20 |
| Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides Chlormethine - Mycosis Fungoides | Not applicable | Completed | Centre for Human Drug Research, Netherlands | 32 | 2021-12-07 | 2023-01-25 |
| Low Dose Total Skin Electron Beam Radiation Therapy and Mechlorethamine Hydrochloride Gel in Treating Patients With Mycosis Fungoides Mechlorethamine Hydrochloride Gel, Total Skin Electron Beam Radiation Therapy - Mycosis Fungoides | Phase 2 | Withdrawn | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2018-08-01 | 2025-04-29 | |
| Valchlor in the Treatment of Lichen Planopilaris Mechlorethamine 0.016% Top Gel - Lichen Planopilaris | Phase 2 | Completed | Mayo Clinic | 12 | 2018-04-01 | 2021-01-28 |
| Effect of Vitamin D After Application With Valchlor 4 placebo, 4 Vitamin D, Valchlor - Skin Irritation | Early Phase 1 | Completed | University Hospitals Cleveland Medical Center | 33 | 2016-11-17 | 2021-12-23 |
| Low Dose Total Skin Electron Beam Treatment (TSEBT) Followed by Maintenance Valchlor for Patients With Mycosis Fungoides Total skin electron beam therapy (TSEBT), mechlorethamine gel 0.016% - Mycosis Fungoides, Cutaneous T-cell Lymphoma | Phase 2 | Unknown | Thomas Jefferson University | 68 | 2016-09-01 | 2016-08-30 |
| Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma Valchlor - Mycosis Fungoides | Completed | Helsinn Therapeutics (U.S.), Inc | 300 | 2014-11-12 | 2020-03-04 |
Mycosis Fungoides (5) · Lymphoma, T-Cell, Cutaneous (3) · Lichen Planus (1) · Neoplasms (1)
Centre for Human Drug Research, Netherlands (1) · Helsinn Therapeutics (U.S.), Inc (1) · Mayo Clinic (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · Soligenix (1) · Thomas Jefferson University (1) · University Hospitals Cleveland Medical Center (1)
United States (5) · Netherlands (1)
Bill Bailey (1) · Jason Sluzevich, MD (1) · Joya Sahu, MD (1) · Kurt Lu, MD (1) · Robert Rissmann, Prof. Dr. (1)
U01AR064144 (1)